These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3783613)

  • 1. p-Dimethoxy-substituted trans-octahydrobenzo[f]- and -[g]quinolines: synthesis and assessment of dopaminergic agonist effects.
    Cannon JG; Amoo VE; Long JP; Bhatnagar RK; Flynn JR
    J Med Chem; 1986 Dec; 29(12):2529-34. PubMed ID: 3783613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Congeners of the beta conformer of dopamine derived from cis- and trans-octahydrobenzo[f]quinoline and trans-octahydrobenzo[g]quinoline.
    Cannon JG; Lee T; Goldman HD; Long JP; Flynn JR; Verimer T; Costall B; Naylor RJ
    J Med Chem; 1980 Jan; 23(1):1-5. PubMed ID: 7188974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cis- and trans-4-n-Propyl-1,2,3,4,4a,5,6,10b-octahydrobenzo(f)quinolines.
    Cannon JG; Koble-Suarez C; Long JP; Ilhan M; Bhatnagar RK
    J Pharm Sci; 1985 Jun; 74(6):672-5. PubMed ID: 4040568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conformationally restricted congeners of dopamine derived from octahydrobenzo[g]quinoline and octahydrobenzo[f]quinoline.
    Cannon JG; Hamer RL; Ilhan M; Bhatnagar RK; Long JP
    J Med Chem; 1984 Feb; 27(2):190-5. PubMed ID: 6694167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rigid congeners of dopamine based on octahydrobenzo[f]quinoline: peripheral and central effects.
    Cannon JG; Suarez-Gutierrez C; Lee T; Long JP; Costall B; Fortune DH; Naylor RJ
    J Med Chem; 1979 Apr; 22(4):341-7. PubMed ID: 571020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of a potential dopaminergic prodrug moiety in several ring systems.
    Cannon JG; Furlano DC; Dushin RG; Chang YA; Baird SR; Soliman LN; Flynn JR; Long JP; Bhatnagar RK
    J Med Chem; 1986 Oct; 29(10):2016-20. PubMed ID: 3761320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monophenolic octahydrobenzo[f]quinolines: central dopamine- and serotonin-receptor stimulating activity.
    Wikström H; Sanchez D; Lindberg P; Arvidsson LE; Hacksell U; Johansson A; Nilsson JL; Hjorth S; Carlsson A
    J Med Chem; 1982 Aug; 25(8):925-31. PubMed ID: 6811743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-substituted 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines and 3-phenylpiperidines: effects on central dopamine and sigma receptors.
    Wikström H; Andersson B; Elebring T; Svensson K; Carlsson A; Largent B
    J Med Chem; 1987 Dec; 30(12):2169-74. PubMed ID: 2824773
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure activity relationships of resorcinol substituted ring systems.
    Ilhan M; Long JP; Flynn J; Bhatnagar R; Cannon JG
    Arch Int Pharmacodyn Ther; 1984 Sep; 271(1):22-32. PubMed ID: 6093720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Centrally acting emetics. 10. Rigid dopamine congeners derived from octahydrobenzo[f]quinoline.
    Cannon JG; Hatheway GJ
    J Med Chem; 1976 Aug; 19(8):987-93. PubMed ID: 184283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the preferred rotameric conformation for dopamine agonist action: an illusory quest.
    Costall B; Lim SK; Naylor RJ; Cannon JG
    J Pharm Pharmacol; 1982 Apr; 34(4):246-54. PubMed ID: 6124599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ha-117 and Ha-118 are potent dopamine receptor agonists.
    Ilhan M; Long JP; Cannon JG
    J Pharm Pharmacol; 1984 Mar; 36(3):213-4. PubMed ID: 6144764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resolved monophenolic 2-aminotetralins and 1,2,3,4,4a,5,6,10b-octahydrobenzo[f]quinolines: structural and stereochemical considerations for centrally acting pre- and postsynaptic dopamine-receptor agonists.
    Wikström H; Andersson B; Sanchez D; Lindberg P; Arvidsson LE; Johansson AM; Nilsson JL; Svensson K; Hjorth S; Carlsson A
    J Med Chem; 1985 Feb; 28(2):215-25. PubMed ID: 3968686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-(Iodopropenyl)-octahydrobenzo[f]- and -[g]quinolines: synthesis and adrenergic and dopaminergic activity studies.
    Tagmatarchis N; Thermos K; Katerinopoulos HE
    J Med Chem; 1998 Oct; 41(21):4165-70. PubMed ID: 9767652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopaminergic activity of cis-trans isomers of benzhydro[f]quinoline analogs.
    Verimer T; Long JP; Rusterholz DR; Flynn JR; Cannon JG; Lee T
    Eur J Pharmacol; 1980 Jun; 64(4):271-7. PubMed ID: 7389823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine receptor stimulating and alpha adrenoceptor blocking actions of trans (CS-265) and cis (CS-263) isomers of nonhydroxylated N-propyl octahydrobenzo[F]quinoline.
    Ilhan M; Long JP; Cannon JG
    J Pharmacol Exp Ther; 1984 Nov; 231(2):361-6. PubMed ID: 6149308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. trans-N-n-Propyl-7-hydroxy-octahydrobenzo(f)quinoline, a rigid 3-PPP analogue with greater potency but lack of selectivity for dopamine autoreceptors.
    Van Oene JC; Houwing HA; Dijkstra D; Horn AS
    Eur J Pharmacol; 1983 Mar; 87(4):491-5. PubMed ID: 6406238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopaminergic structure-activity relationships of 2-aminoindans and cardiovascular action and dopaminergic activity of 4-hydroxy, 5-methyl, 2-di-n-propylaminoindan (RD-211).
    Ma SX; Long JP; Flynn JR; Leonard PA; Cannon JG
    J Pharmacol Exp Ther; 1991 Feb; 256(2):751-6. PubMed ID: 1671601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of ergolines to hexahydro- and octahydrobenzo[f]quinolines (depyrroloergolines).
    Bach NJ; Kornfeld EC; Clemens JA; Smalstig EB
    J Med Chem; 1980 Jul; 23(7):812-4. PubMed ID: 7190615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and dopaminergic activity of 2-substituted octahydrobenzo[f]quinolines.
    Craig JC; Torkelson SM; Findell PR; Weiner RI
    J Med Chem; 1989 May; 32(5):961-8. PubMed ID: 2565402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.